Roudier, EmileLam, Brian2020-03-062020-03-062019Lam B and Roudier E (2019) Considering the Role of Murine Double Minute 2 in the Cardiovascular System? Front. Cell Dev. Biol. 7:320. doi: 10.3389/fcell.2019.00320https://doi.org/10.3389/fcell.2019.00320https://hdl.handle.net/10315/37064The E3 ubiquitin ligase Murine double minute 2 (MDM2) is the main negative regulator of the tumor protein p53 (TP53). Extensive studies over more than two decades have confirmed MDM2 oncogenic role through mechanisms both TP53-dependent and TP53-independent oncogenic function. These studies have contributed to designate MDM2 as a therapeutic target of choice for cancer treatment and the number of patents for MDM2 antagonists has increased immensely over the last years. However, the question of the physiological functions of MDM2 has not been fully resolved yet, particularly when expressed and regulated physiologically in healthy tissue. Cardiovascular complications are almost an inescapable side-effect of anti-cancer therapies. While several MDM2 antagonists are entering phase I, II and even III of clinical trials, this review proposes to bring awareness on the physiological role of MDM2 in the cardiovascular system.enArticlehttps://www.frontiersin.org/journals/cell-and-developmental-biologyhttps://www.frontiersin.org/https://www.frontiersin.org/articles/10.3389/fcell.2019.00320/full